Head of Boots pharmacy chain to depart as owner Walgreens struggles
By Mike Murphy and Ciara Linnane
Sebastian James is leaving the company in November for another role in healthcare
The head of British pharmacy chain Boots is stepping down, the company said Monday, confirming media reports that come amid turmoil for parent company Walgreens Boots Alliance Inc.
Sebastian James has given Walgreens (WBA) notice that he will leave his post as Boots managing director in November to pursue a new role in the healthcare sector, the company said in a statement. The news comes after plans to sell Boots or publicly list its stock have stalled.
On Thursday, Walgreens stock plunged 25% to a 27-year-low, after the drugstore chain's quarterly profit fell short of expectations and its earnings outlook was lowered. The company plans to close thousands of underperforming stores as part of a plan to cut costs by $1 billion this year. Walgreens also said it had no plans to sell Boots-whose recent sales growth is one of the company's bright spots-but would continue to invest in it.
"We continue to face a difficult operating environment," Chief Executive Tim Wentworth said in a statement Thursday.
James was named managing director of Boots in 2018. Under his stewardship, the company has delivered 13 straight quarters of retail market share growth, said the Walgreens statement.
The company has started to search for a replacement managing director.
Shares of Walgreens Boots Alliance have sunk more than 53% year to date, compared with the S&P 500's SPX 14.5% gain.
-Mike Murphy -Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-01-24 0703ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying
-
The 10 Best Companies to Invest in Now